```

                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-QSB

               QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934

                For the quarterly period ended September 30, 2003

                          Commission File No. 333-94265

                              LISKA BIOMETRY, INC.
        (Exact name of small business issuer as specified in its charter)

                Florida                                    061562447
    (State or other jurisdiction of                    (I.R.S. Employer
     incorporation or organization)                  Identification Number)

               6066 Vineyard Drive, Ottawa, Ontario Canada K1C 2M5
               (Address of principal executive offices) (Zip Code)

                                 (613) 949-0915
              (Registrant's telephone number, including area code)

                             All Correspondence to:
                          Brenda Lee Hamilton, Esquire
                         Hamilton, Lehrer & Dargan, P.A.
                          2 East Camino Real, Suite 202
                            Boca Raton, Florida 33432
                            Telephone (561) 416-8956
                            Facsimile (561) 416-2855

Registrant has filed all reports  required to be filed by Section 13 or 15(d) of
the Securities  Exchange Act of 1934 during the preceding 12 months and has been
subject to such filing requirements for the past 90 days. [X] Yes [ ] No

                      APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the registrant's classes of
common stock, as of the latest practical date: As of November 11, 2003, we had
15,134,275 shares of our common stock outstanding held by 73 shareholders of
record.

             (The remainder of this page intentionally left blank.)

                                      INDEX
                                                                          Page
PART I - FINANCIAL INFORMATION

Item 1 - Financial Statements
         Consolidated Balance Sheet (Unaudited)............................1
         Consolidated Statements of Operations (Unaudited).................2
         Consolidated Statements of Cash Flows (Unaudited).................3
         Notes to Financial Statements....................................4-6

Item 2 - Management's Discussion and Analysis or Plan of Operations........7

Item 3 - Controls and Procedures..........................................15

PART II - OTHER INFORMATION

Item 1 - Legal Proceedings................................................15
Item 2 - Changes in Securities............................................15
Item 3 - Default Upon Senior Securities...................................19
Item 4 - Submission of Matters to a Vote of Security Holders..............19
Item 5 - Other Information................................................19
Item 6 - Exhibits and Reports on Form 8-K.................................19

                         **PART I - FINANCIAL INFORMATION**Financial Statements

                              Liska Biometry, Inc.
                          (A Development Stage Company)
                           Consolidated Balance Sheet
                               September 30, 2003
                                   (Unaudited)

Assets

Current assets:
      Cash                                                   $         478
                                                            ===============

Liabilities and stockholders' (deficit)

Current liabilities:
   Accounts payable and accrued expenses                     $     136,506
   Due to investors                                                 35,000
                                                            ---------------
          Total current liabilities                                171,506
                                                            ---------------

Stockholders' (deficit):
   Preferred stock, no par value,
       10,000,000 shares authorized                                      -
   Common stock, no par value,
      100,000,000 shares authorized,
      13,058,275 shares issued and outstanding                     924,829
   Additional paid in capital                                    1,059,546
  (Deficit) accumulated during the development stage            (2,154,217)
                                                            ---------------
                                                                  (169,842)
  Other comprehensive income:
    Foreign exchange translation adjustment                         (1,186)
                                                            ---------------
                                                                  (171,028)
                                                            ---------------

                                                             $         478
                                                            ===============

      See the accompanying notes to the consolidated financial statements.

                                      -1-

                              Liska Biometry, Inc.
                          (A Development Stage Company)
                      Consolidated Statements of Operations
       Three Months and Nine Months Ended September 30, 2003 and 2002 and
                Inception (August 1, 2000) to September 30, 2003
                                   (Unaudited)

                                        Three Months     Three Months     Nine Months    Nine Months      Inception
                                           Ended            Ended           Ended           Ended             to
                                       Sept 30, 2003    Sept 30, 2002   Sept 30, 2003   Sept 30, 2002   Sept 30, 2003
                                      ---------------  --------------  --------------  --------------  --------------

Sales                                 $           -    $          -    $          -    $          -    $       8,000

Cost of goods sold                                -               -               -               -              892
                                      ---------------  --------------  --------------  --------------  --------------
Gross profit                                      -               -               -               -            7,108

Operating expenses:
   Impairment of license                          -               -               -               -           58,812
   Selling, general and
     administrative expenses                 159,590          12,218         259,470          24,225       2,102,763
                                      ---------------  --------------  --------------  --------------  --------------
                                             159,590          12,218         259,470          24,225       2,161,575
                                      ---------------  --------------  --------------  --------------  --------------

(Loss) from operations                      (159,590)        (12,218)       (259,470)        (24,225)     (2,154,467)
                                      ---------------  --------------  --------------  --------------  --------------

Other income (expense):
   Other income                                   -               -               -               -              250
                                      ---------------  --------------  --------------  --------------  --------------
Net (loss)                            $     (159,590)  $     (12,218)  $    (259,470)  $     (24,225)  $  (2,154,217)
                                      ===============  ==============  ==============  ==============  ==============
Per share information -
     basic and fully diluted:
  Weighted average shares outstanding     12,957,275       9,898,275      11,039,038       9,898,275       3,086,834
                                      ===============  ==============  ==============  ==============  ==============
  Net (loss) per share                $        (0.01)  $       (0.00)  $       (0.02)  $       (0.00)  $       (0.70)
                                      ===============  ==============  ==============  ==============  ==============

      See the accompanying notes to the consolidated financial statements.

                                      -2-

                              Liska Biometry, Inc.
                          (A Development Stage Company)
                      Consolidated Statements of Cash Flows
                Nine Months Ended September 30, 2003 and 2002 and
                Inception (August 1, 2000) to September 30, 2003
                                   (Unaudited)

                                             Nine Months       Nine Months        Inception
                                                Ended             Ended              to
                                            Sept 30, 2003     Sept 30, 2002     Sept 30, 2003
                                           ---------------   ---------------   --------------
Cash flows from operating activities:
Net cash (used in) operating activities     $     (55,138)    $        (718)    $   (137,377)
                                           ---------------   ---------------   --------------

Cash flows from investing activities:
Net cash (used in) investing activities                 -                 -          (50,000)
                                           ---------------   ---------------   --------------

Cash flows from financing activities:
Net cash provided by financing activities          55,000               855          187,855
                                           ---------------   ---------------   --------------

Net increase (decrease) in cash                      (138)              137              478
Beginning - cash balance                              616                 -                -
                                           ---------------   ---------------   --------------

Ending - cash balance                       $         478     $         137     $        478
                                           ===============   ===============   ==============

      See the accompanying notes to the consolidated financial statements.

                                      -3-

                              LISKA BIOMETRY, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2003
                                   (UNAUDITED)

(1)      Basis Of Presentation

The accompanying unaudited consolidated financial statements have been prepared
in accordance with generally accepted accounting principles (GAAP) for interim
financial information and Item 310(b) of Regulation S-B. They do not include all
of the information and footnotes required by GAAP for complete financial
statements. In the opinion of management, all adjustments (consisting only of
normal recurring adjustments) considered necessary for a fair presentation have
been included.

The results of operations for the periods presented are not necessarily
indicative of the results to be expected for the full year. For further
information, refer to the financial statements of the Company as of December 31,
2002 and for the two years then ended, and the period from inception (August 1,
2000) to December 31, 2002, including notes thereto included in the Company's
Form 10-KSB.

(2)      Earnings Per Share

The Company calculates net income (loss) per share as required by Statement of
Financial Accounting Standards (SFAS) 128, "Earnings per Share." Basic earnings
(loss) per share is calculated by dividing net income (loss) by the weighted
average number of common shares outstanding for the period. Diluted earnings
(loss) per share is calculated by dividing net income (loss) by the weighted
average number of common shares and dilutive common stock equivalents
outstanding. During periods when anti-dilutive commons stock equivalents are not
considered in the computation.

(3)      Income Taxes

The Company accounts for income taxes under SFAS 109, which requires use of the
liability method. SFAS 109 provides that deferred tax assets and liabilities are
recorded based on the differences between the tax bases of assets and
liabilities and their carrying amounts for financial reporting purposes,
referred to as temporary differences. Deferred tax assets and liabilities at the
end of each period are determined using the currently enacted tax rates applied
to taxable income in the periods in which the deferred tax assets and
liabilities are expected to be settled, or realized.

The provision for income taxes differs from the amount computed by applying the
statutory federal income tax rate to income before provision for income taxes.
The sources and tax effects of the differences are as follows:

         Income tax provision at
          the federal statutory rate                 34 %
         Effect of operating losses                 (34)%
                                                   ------
                                                      -

As of September 30, 2003, the Company has a net operating loss carryforward of
approximately $2,100,000 subject to any restrictions because of a change in
ownership. This loss will be available to offset future taxable income. If not
used, this carryforward will expire through 2023. The deferred tax asset of
approximately $700,000 relating to the operating loss carryforward has been
fully reserved at September 30, 2003.

                                      -4-

(4)      Commitments and Contingencies

During the periods covered by these financial statements the Company issued
shares of common stock without registration under the Securities Act of 1933.
Although the Company believes that the sales did not involve a public offering
of its securities and that the Company did comply with the "safe harbor"
exemptions from registration, it could be liable for rescission of the sales if
such exemptions were found not to apply and this could have a material negative
impact on the Company's financial position and results of operations.

During the periods covered by these financial statements the Company entered
into several employment, consulting and other agreements with third parties.
Although the Company obtained settlement releases from a majority of the
parties, settlement releases were not entered into with some of these parties or
the settlement releases were verbal agreements. Future contingencies which
cannot be estimated by management, may exist for the above matters including but
not limited to issuance of capital stock and other financial obligations and may
have a material negative impact on the Company's financial position and results
of operations.

(5)      Stockholders' (Deficit)

During the nine months ended September 30, 2003 an affiliate of the Company
contributed $4,555 to the capital of the Company. In addition, this affiliate
converted amounts paid directly for expenses on behalf of the Company in the
amount of $64,152 into 150,000 shares of common stock.

During August 2002 the Company entered into an agreement with a consultant
whereby the consultant would provide financial consulting services to the
Company. Pursuant to the agreement the Company is to pay a monthly fee of $5,000
for these services. In addition, the consultant will receive 1,000,000 shares of
the Company's common stock, provided that within 12 months of the date of the
agreement the consultant provided sufficient working capital to develop the
Company's product. As of June 1, 2003 $55,000 in unpaid fees had been accrued
and the Company has received no working capital from the consultant. In June
2003 the consultant agreed to accept 1,000,000 shares of common stock in
settlement of any amounts due from the Company.

During July 2003 the Company issued 1,900,000 shares of common stock for
services. The shares were valued at their fair market value of $.055 per share
or $104,500, which amount was charged to operations during the period.

During August and September 2003 the Company issued 110,000 shares of common
stock in exchange for cash aggregating $55,000.

(6)      Basis of Reporting

The Company's financial statements are presented on a going concern basis, which
contemplates the realization of assets and satisfaction of liabilities in the
normal course of business.

The Company has experienced a significant loss from operations as a result of
its investment necessary to achieve its operating plan, which is long-range in
nature. For the nine months ended September 30, 2003 and the period from
inception to September 30, 2003, the Company incurred net losses of $259,470
and $2,154,217 and has working capital and stockholder deficits of $171,028 at
September 30, 2003. In addition, the Company has no revenue generating
operations.

                                      -5-

The Company's ability to continue as a going concern is contingent upon its
ability to attain profitable operations and secure financing. In addition, the
Company's ability to continue as a going concern must be considered in light of
the problems, expenses and complications frequently encountered by entrance into
established markets and the competitive environment in which the Company
operates.

The Company is pursuing equity financing for its operations. Failure to secure
such financing or to raise additional capital or borrow additional funds may
result in the Company depleting its available funds and not being able pay its
obligations.

The financial statements do not include any adjustments to reflect the possible
future effects on the recoverability and classification of assets or the amounts
and classification of liabilities that may result from the possible inability of
the Company to continue as a going concern.

(7)      Subsequent Event

During October 2003 the Company issued 2,000,000 shares of its common stock for
services to affiliates, and certain consultants. These shares will be valued at
their fair market value on the date it was agreed they would be issued and the
value will be charged to operations.

                                      -6-
Plan of Operations

FORWARD-LOOKING STATEMENTS
The following discussion and analysis contains forward looking statements and
should be read in conjunction with our financial statements and related notes.
For purposes of this Plan of Operations, Liska Biometry, Inc. is referred to
herein as "we," "us," or "our." This discussion and analysis contains
forward-looking statements based on our current expectations, assumptions, and
estimates. The words or phrases "believe," "expect," "may," "should,"
"anticipates" or similar expressions are intended to identify "forward-looking
statements." Actual results could differ materially from those projected in the
forward-looking statements as a result of a number of risks and uncertainties,
including the following: (a) our ability to continue as a going concern is
contingent upon our ability to attain profitable operations and secure
financing; (b) because we have no operating history or revenues or products
pertaining to our biometrics based business, it will be difficult for you to
evaluate our business and financial prospects; (c) because we are a new
business, we are subject to financial and operational risks; (d) if we fail to
keep pace with the rapidly changing market of fingerprint identification, our
revenues and financial condition will be negatively affected; (e) we may be
unable to overcome competitive forces; (f) we face patent protection risks; and
(g) other risk factors which are discussed in our Form 10-KSB for the period
ending December 31, 2002 which may be reviewed at www.sec.gov.

OUR OPERATIONS FROM OUR INCEPTION TO SEPTEMBER 2003:
Corporate History
We are a development stage company that was formed to engage in the business of
selling mortgage related products on the Internet. After a period of inactivity,
in approximately late April 2001, we changed our business plan to engage in the
marketing of a cleaning process for large-scale water and fluid treatment,
filtering, and storage facilities. On August 1, 2000, we obtained from Floran
Technologies, Inc. a license to market, sell, and distribute rights from certain
cleaning process technologies for large-scale water and fluid treatment,
filtering, and storage facilities. On April 30, 2001, Floran Technologies, Inc.
notified us that it was terminating the license agreement due to our default on
payments we were required to make to it. As a result of the license termination,
we became inactive.

On May 10, 2001 we enacted a one hundred (100) for one (1) reverse split of our
common stock. From May of 2001 until March of 2002 we were inactive.

On March 26, 2002, Paragon Management and Marketing, Inc., our majority
shareholder at the time, sold 9,000,000 shares of our common stock to Kojon
Biometrics, Inc., a Canadian Corporation, in exchange for $100,000. Of this
amount, Kojon Biometrics, Inc. paid $40,000 in cash. Paragon Management and
Marketing, Inc. exchanged the remaining balance due for 100,000 shares of Kojon
Biometric, Inc's common stock. Lam Ko Chau, our President and sole director, is
the majority shareholder of Kojon Biometrics, Inc. through his ownership of
3,500,000 shares or 60% of Kojon Biometrics, Inc.'s common stock. Lam Ko Chau is
the President and a Director of Kojon Biometrics, Inc. As a result of the
transaction:
     o    Kojon Biometrics, Inc. then held 9,000,000 shares of our common stock
          which represented approximately ninety-one percent (91%) of our common
          stock;
     o    Lyndell Parks, our then President and Director, and Audra Parks, our
          then Secretary, Treasurer and Director, resigned all positions they
          held with us and appointed Lam Ko Chau as our President and sole
          member of our Board of Directors to fill the vacancies created by
          their resignations; and
     o    We changed our name to Liska Biometry, Inc. to reflect our new
          proposed business plan of fingerprint encoding and authentication.

                                      -7-

Since the March 26, 2002 stock sale to Kojon Biometrics, Inc., Lam Ko Chau has
been our controlling shareholder, President, and sole director.

At the time of the purchase of the 9,000,000 shares by Kojon Biometrics, Inc.,
Lam Ko Chau was an officer, director and the majority shareholder of Kojon
Biometrics, Inc. through his ownership of 3,500,000 shares or sixty percent
(60%) of Kojon Biometrics, Inc.'s common stock. Lam Ko Chau, our President,
founded Kojon Biometrics, Inc. and has been its President and Chief Executive
Officer since April 17, 2001. On April 5, 2003, Kojon Biometrics, Inc.
distributed the 9,000,000 shares of our common stock it had purchased on March
26, 2002 to its fifteen (15) shareholders.

On August 1, 2003, we issued 150,000 shares of our common stock to Kojon
Biometrics, Inc., in exchange for consulting services for research and
development, rendered by Lam Ko Chau, on behalf of Kojon Biometrics, Inc. and to
reimburse expenses paid by Kojon in the amount of $64,152. On August 14, 2003,
Kojon distributed 60,000 of these shares to its shareholder, B Investments,
Inc., an Oregon corporation, which is owned and controlled by Jean Babalis. On
August 14, 2003, Kojon distributed 16,000 of these shares to its shareholder,
Protec International SA, a Belize corporation, which is controlled by Richard
C. Pike. On August 14, 2003, Kojon distributed 20,000 of these shares to its
shareholder, Spencer Chen. On August 14, 2003, Kojon distributed 40,000 of these
shares to its shareholder, G. Bryan Thomas.

Intellectual Property
Our President, Lam Ko Chau, having previously made certain inventions and
discoveries, filed the following patents with the United States Patent and
Trademark Office for a method and system for fingerprint encoding and
authentication: (a) US Provisional Patent Application Serial No. 60/312,371,
entitled "Method and System for Fingerprint Encoding and Authentication," filed
on August 16, 2001; and (b) US Patent Application Serial No. 09/965,809,
entitled "Method and System for Fingerprint Encoding and Authentication," filed
on October 1, 2001. On August 15, 2002, our President, Lam Ko Chau, filed a PCT
International Patent Application PCT/CA02/01274, entitled "Method and System for
Fingerprint Encoding and Authentication" with the World Intellectual Property
Organization. The World Intellectual Property Organization, headquartered in
Geneva, Switzerland, is an international organization dedicated to promoting the
use and protection of intellectual property works. As of July 28, 2003, none of
these patent applications have been approved. On February 27, 2003, our
President, Lam Ko Chau, assigned the right, title and interest to all of these
patent applications to us for consideration of $1. This assignment forms the
basis of our plan to engage in the fingerprint encoding and authentication
business.

We do not expect to generate any meaningful revenue or incur any significant
operating expenses until such time that we formulate our Plan of Operations and
begin meaningful operations in our proposed business of fingerprint encoding and
authentication; however, we will continue to incur expenses pertaining to
operations, legal and accounting related expenses pertaining to our periodic and
other reporting obligations with the Securities and Exchange Commission.

                                      -8-

Material Agreements
Agreement with Chris LeClerc
On August 11, 2003, we entered into an agreement with Christopher J. LeClerc, to
provide us with services as our Chief Operating Officer. Mr. LeClerc's services
are to begin upon such dates as we receive funding in the amount of $100,000. If
we do not receive funding on or before December 31, 2003, the agreement will
become null and void. We are required to pay Mr. LeClerc an annual salary of
$48,000 for his services, which will be paid bi-weekly in arrears once Mr.
LeClerc's services are commenced, if ever. Mr. LeClerc is eligible to
participate in any stock option plan that we establish and is eligible to
receive an annual bonus as determined by our Board of Directors. Mr. LeClerc may
terminate the agreement at any time upon 90 days written notice to our Board of
Directors. We may terminate the agreement at any time with or without cause. We
may be unable to receive funding in the amount of $100,000 upon acceptable terms
or at all; as such, Mr. LeClerc may never serve as our Chief Operating Officer.

Agreement with Jeffrey L. Hall
On August 11, 2003, we entered into an agreement with Jeffrey L. Hall, to
provide us with services as our Vice President of Marketing. Mr. Hall's services
are to begin upon such dates as we receive funding in the amount of $100,000. If
we do not receive funding on or before December 31, 2003, the agreement will
become null and void. We are required to pay Mr. Hall an annual salary of
$48,000 for his services, which will be paid bi-weekly in arrears once Mr.
Hall's services are commenced, if ever. Mr. Hall is eligible to participate in
any stock option plan that we establish and is eligible to receive an annual
bonus as determined by our Board of Directors. Mr. Hall may terminate the
agreement at any time upon 90 days written notice to our Board of Directors. We
may terminate the agreement at any time with or without cause. We may be unable
to receive funding in the amount of $100,000 upon acceptable terms or at all; as
such, Mr. Hall may never serve as our Vice President of Marketing.

FUTURE PLAN OF OPERATIONS

Our Plan of Operations is contingent upon receiving adequate financing to meet
estimated costs of $1,077,250. Currently, we do not have sufficient funds to
conduct any aspect of our Plan of Operations. In addition, we have not located a
financing source which would provide us with sufficient funds to implement our
Plan of Operations. If and only if we are able to obtain funding of $1,077,250,
we plan to conduct the following Plan of Operations over a period of twelve
months

Appoint Executive Management Team
We will attempt to fill the following full-time positions as our executive
management:
     o    Chief Operating Officer;
     o    Chief Financial Officer; and
     o    Vice President - Sales & Marketing

We estimate total annual salary expenditures of $198,000, composed of a $48,000
salary for each of the above positions. In addition, our Chief Executive
Officer's salary will be $54,000.

                                      -9-

Hire Engineering Team
We plan to hire the following positions that will comprise our engineering team
which will develop our fingerprint technology:
     o    One Chief Scientist;
     o    Two full-time software engineers; and
     o    One full-time software/hardware engineer.

The annual salary costs associated with these positions is $120,000, comprised
of the following annual salaries: (a) Chief Scientist $12,000; and (b) three
Engineers each at $36,000.

Capital Expenditures
We intend to purchase capital equipment for our research and development, which
will consist primarily of computer hardware. The estimated cost of this
equipment is approximately $12,500.

Engage Business Development Consultants
We intend to contract out our business development function to consultants, who
will identify marketing opportunities for our products and services. The
estimated annual expenditures for the business development consultants are
$60,000.

Engage Research and Development Consultants
We intend to utilize five consultants for research and development in
manufacturing, engineering and other research and development needs. These
consultants will deliver solutions to the ongoing development of our products
and services. The annual estimated costs associated with these consultants are
$90,000.

Research and Development of Fingerprint Science
We intend to study the relationship between a solid fingertip and its
fingerprint impression, and the transfer of unique characteristics from the
source to the samples. This research will be conducted by the engineering team
that we hire, as referred to above under "Hire Engineering Team." The purpose of
this research is to enhance the dependability of the fingerprint scanner device
that we develop. The total expenditure for this study will be $5,000.

Develop and Initiate Marketing Effort
Our Vice President of Marketing will survey key markets and customers to develop
a strategy for brand name recognition, including marketing efforts associated
with the following government agencies:
     o    Department of Defense Biometrics Management Office and Joint
          Interoperability Test Command;
     o    United States Army Communication Electronics Command;
     o    National Institute for Standards in Technology;
     o    National Security Agency; and
     o    Justice Department Management Office.

                                      -10-

In addition, we will acquire other market information and contacts by joining
key industry groups and hiring industry analysts. The annual cost associated
with this marketing effort is $45,000.

Develop Software Algorithms
We will use third party developed live-scan fingerprint scanners to develop our
initial proprietary software algorithms to reach our proof of concept stage and
illustrate the differentiating features of our embedded software algorithms -
that is, the capability to measure the stable content of a fingerprint image and
to express it as a short numeric output. For a given legible and distinct
fingerprint input, the output number is expected to be distinct from person to
person. Our algorithm development will be directed by our President, Lam Ko
Chau, and accomplished by a team of engineers. We estimate that the total
expenditure for algorithm development will be $10,000.

Development of Fingerprint Scanner Prototype
We will attempt to build our own scanner to the specifications of our
patent-pending algorithms. We estimate that the cost of outsourcing labor and
materials to build this scanner will be approximately $100,000.

Manufacturing
We will pre-qualify prospective contract third-party manufacturing firms to
manufacture our fingerprint technology-related products. We expect that most of
the technological components of the fingerprint scanner can also be outsourced
to third-party manufacturers.

Hire Director of Manufacturing
We will also interview and hire a Director of Manufacturing who will be required
to have a background in electro-optical and mechanical engineering. Our Director
of Manufacturing will oversee the manufacturing process of our third party
manufacturers for quality control purposes. We intend to hire the Director of
Manufacturing at a maximum annual salary of $60,000.

Testing of Prototype
We will submit our prototype product to the following government regulatory
agencies:
     o    Department of Defense Biometrics Management Office, which provides
          testing and analysis of biometric products to be considered by the
          Department of Defense;
     o    National Institute for Standards and Technology, which performs
          acceptance testing for the Department of Justice Management Division;
          and
     o    Joint Interoperability Test Command, which makes sure those persons,
          machines and computers across all branches of the military can
          communicate with each other.

                                      -11-

We will also consult with commercial organizations that set standards in the
commercial sector, including BioAPI Consortium, the International Biometrics
Group, and the International Biometrics Industry Association, to design and
build a fingerprint technology system that: (a) meets customer needs on an
up-to-date basis; (b) has the ability to operate and integrate two or more
different systems, such as the Federal Bureau of Investigation that uses a "10
rolled print" identification process and the Immigration and Naturalization
Service which uses a "2 index finger plain print" identification process; and
(c) meets Department of Defense regulations and criteria and interoperability
guidelines.

Hire Business Development Manager, Applications Engineer, and Marketing Programs
Manager
During our prototype testing stage, as reflected above, we will hire an
experienced Business Development Manager, an Applications Engineer, and
Marketing Programs Manager. We intend to pay the following salaries: (a)
Business Development Manager $60,000; (b) Applications Engineer $36,000; and
(c) Marketing Programs Manager $36,000. Compensation will include base salary,
bonuses and stock options.

Marketing

Marketing expenditures will focus on the broad dissemination of our test
results. By using a biometrics knowledgeable public relations firm, we will
attempt to increase our market recognition, provide promotional sampling of our
products, and target key customers. We will attempt to develop strategic
partners to collaborate on our marketing and technological integration efforts.
Such strategic partners may include the following:
     o    Facial and eye recognition (Iris and Retina) system vendors;
     o    Federal security suppliers and contractors;
     o    Military sourcing organizations; and
     o    Other distribution channels that target military and commercial
          security markets.

We will use the following prospecting and marketing techniques:
     o    Phone and meet with existing and retired military personnel,
          especially those that are or were employed by the Immigration and
          Naturalization  Service, all branches of the United States military,
          the Federal Bureau of Investigation, and the National Security Agency;
     o    We will determine from prospective and actual commercial and
          government clients what their existing needs are for a biometric based
          system;
     o    We will use information from the following sources to determine trends
          in the commercial and government markets: (a) biometric organizations;
          (b) our own general market study; and (c) conduct research on the
          Internet regarding our competition.

                                      -12-

The approximate expenditure for the second phase of our marketing campaign,
including compensation is $215,000.

Open and Operate United States Office
We plan to open a United States office to establish a United States presence of
our proposed product and our brand name. The purpose of this United States
office will be to market, sell, and third party manufacture our products in the
United States. This office will be staffed by: (a) Chief Operating Officer; (b)
Vice President of Marketing and Sales; and (c) Director of Manufacturing. Each
of these individuals will earn a salary of $48,000 for total salary costs of
$144,000. The approximate expenditures for opening and operating the United
States office is $17,750.

Financial Considerations
We have no cash resources from which to conduct any operations or pursue our
proposed business plan. As of September 30, 2003, we had $478 of cash;
accordingly, we will be unable to fund any operations from our current cash
position. Although our President plans to loan us funds to conduct our
operations, we have no agreement with our President to do so and our President
is under no obligation to loan us funds. Accordingly, there are no assurances
that we will receive loans from our President. Moreover, there are no assurances
that our President will have sufficient funds to make these loans. In addition,
we have no compensation agreements to our President in connection with any loans
he may provide to us. If our President is unable or unwilling to make loans to
us necessary to implement our Plan of Operations, we will need additional
financing through traditional bank financing or a debt or equity offering;
however, because we are a development stage company with no operating history
and a poor financial condition, we may be unsuccessful in obtaining such
financing or the amount of the financing may be minimal and therefore inadequate
to implement our Plan of Operations. In addition, if we only have nominal funds
by which to conduct our operations, we may have to curtail any potential Plan of
Operations which would negatively impact development of any potential brand name
and reputation. In the event that we do not receive financing or our financing
is inadequate to enable us to conduct potential operations, we may have to
liquidate our business and undertake any or all of the following actions:
     o    Sell or dispose of our assets, if any;
     o    Pay our liabilities in order of priority, if we have available cash to
          pay such liabilities;
     o    If any cash remains after we satisfy amounts due to our creditors,
          distribute any remaining cash to our shareholders in an amount equal
          to the net market value of our net assets;
     o    File a Certificate of Dissolution with the State of Florida to
          dissolve our corporation and close our business;
     o    Make the appropriate filings with the Securities and Exchange
          Commission so that we will no longer be required to file periodic and
          other required reports with the Securities and Exchange Commission,
          if, in fact, we are a reporting company at that time; and/or
     o    Make the appropriate filings with the National Association of Security
          Dealers to affect a delisting of our common stock from the OTC
          Bulletin Board.

                                      -13-

Based upon our current assets, however, we will not have the ability to
distribute any cash to our shareholders.

If we have any liabilities that we are unable to satisfy and we qualify for
protection under the U.S. Bankruptcy Code, we may voluntarily file for
reorganization under Chapter 11 or liquidation under Chapter 7. Our creditors
may also file a Chapter 7 or Chapter 11 bankruptcy action against us. If our
creditors or we file for Chapter 7 or Chapter 11 bankruptcy, our creditors will
take priority over our shareholders. If we fail to file for bankruptcy under
Chapter 7 or Chapter 11 and we have creditors, such creditors may institute
proceedings against us seeking forfeiture of our assets, if any.

We do not know and cannot determine which, if any, of these actions we may be
forced to take.

LIQUIDITY AND CAPITAL RESOURCES
As of September 30, 2003, we had limited cash resources of $478. We do not have
any other internal sources of working capital. As of September 30, 2003, all
required administrative expenses are being paid by our President and from sales
of our common stock.

We did not receive any revenues during the 12 months ended September 30, 2003.
We do not anticipate earning revenues, if any, until such time as we accomplish
our Plan of Operations in the fingerprint encoding and authentication business.
Our Plan of Operations will be subject to receiving substantial financing, which
we may be unable to obtain.

At the present time, we have insufficient working capital to fund our planned
growth and ongoing operating expenses. As a result, we expect to continue to
experience significant negative operating cash flow for the foreseeable future.
Our existing working capital will not be sufficient to fund the continued
implementation of our future Plan of Operations and to meet our general
operating expenses. We are unable to predict at this time the exact amount of
additional working capital we will require; however, in order to provide any
additional working capital which we may require, in all likelihood we will be
required to raise additional capital through the sale of equity securities which
is subject to the following significant risks: (a) there can be no assurance
that equity financing will be available as needed or on terms favorable to us;
and (b) equity financing may dilute the ownership of our shareholders. We
currently have no firm commitments from any party to provide us with any
additional working capital or any type of financing. If we do not have
sufficient working capital, it is likely that we will have to cease operations.

                                      -14-

RESULTS OF OPERATIONS:
We have never had revenues from operations. Our accumulated losses since our
inception were incurred for our formation and operating expenses. As of
approximately March 2002, in connection with our change of control, we decided
to pursue a business plan consisting of providing fingerprint encoding and
authentication services; however, to date, we have not accomplished any steps
towards developing this business plan.

Controls and Procedures
The Company's Principal Executive Officer and Principal Financial Officer
evaluated the Company's disclosure controls and procedures within the 90 days
preceding the filing date of this quarterly report. Based upon this evaluation,
the Principal Executive Officer and Principal Financial Officer concluded that
the Company's disclosure controls and procedures are effective in ensuring that
material information required to be disclosed is included in the reports that it
files with the Securities and Exchange Commission.

There have been no significant changes in our internal control over financial
reporting during the quarter ended September 30, 2003, or subsequent to
September 30, 2003 that have materially affected or are reasonably likely to
materially affect, our internal control over financial reporting.

                                     **PART II**Legal Proceedings
We may become subject to legal proceedings in our business. We are not aware of
any legal proceedings which will likely have a material affect on our business.

Changes in Securities
On June 26, 2003, we issued 1,000,000 shares of our common stock to Lane Capital
Markets, LLC as payment for services rendered to us and for $55,000 which we
owed to Lane Capital Markets, LLC for services rendered to us. Lane Capital
Markets, LLC is owned by John Lane. We valued these shares at a price of $0.055
per share or aggregate of $55,000. We relied upon Section 4(2) and Rule 506 of
Regulation D of the Act for the sale. We believed that Section 4(2) and Rule 506
were available because the sale did not involve a public offering and there was
no general solicitation or general advertising involved in the sale. John Lane
had a pre-existing relationship with Lam Ko Chau, our sole Officer and Director.
We placed legends on the stock certificates stating that the securities were not
registered under the Securities Act of 1933 ("Securities Act") and set forth the
restrictions on their transferability and sale.

                                      -15-

On July 25, 2003, we issued 1,200,000 shares of our common stock to Christopher
J. LeClerc and on October 23, 2003, we issued an additional 1,500,000 shares of
our common stock to Christopher J. LeClerc. We issued an aggregate of 2,700,000
shares to Mr. LeClerc in exchange for consulting services relating to our
business development. These services were rendered to us from January 1, 2001
until September 30, 2003. We valued 1,200,000 shares at $0.055 per share or an
aggregate of $66,000; we valued 1,500,000 shares at $.50 per share or an
aggregate of $750,000. We relied upon the exemption provided in Section 4(2) and
Rule 506 of Regulation D of the Securities Act for the offer and sale of the
shares. We believed that Section 4(2) was available because the offer and sale
did not involve a public offering and there was no general solicitation or
general advertising involved in the sale. Christopher J. LeClerc had a
pre-existing relationship with Lam Ko Chau, our sole Officer and Director. We
placed legends on the stock certificates stating that the securities were not
registered under the Securities Act and set forth the restrictions on their
transferability and sale.

On July 29, 2003, we issued 400,000 shares of our common stock to Manoj Hippola
in exchange for consulting services relating to our financial Audit procedures
and financial controls, budgeting and Administrative filings, rendered to us
between November 7, 2001 and July 25, 2003. We valued these shares at $0.055 per
share or an aggregate of $22,000. We relied upon the exemption provided in
Section 4(2) and Rule 506 of Regulation D of the Securities Act for the offer
and sale of the shares. We believed that Section 4(2) was available because the
offer and sale did not involve a public offering and there was no general
solicitation or general advertising involved in the sale. Manoj Hippola had a
pre-existing relationship with Lam Ko Chau, our sole Officer and Director. We
placed legends on the stock certificates stating that the securities were not
registered under the Securities Act and set forth the restrictions on their
transferability and sale.

On July 29, 2003, we issued 150,000 shares of our common stock to Jeffrey Hall
in exchange for consulting services relating to industry analysis and business
development, rendered to us between January 1, 2003 and July 25, 2003. We valued
these shares at $0.055 per share or an aggregate of $8,250. We relied upon the
exemption provided in Section 4(2) and Rule 506 of Regulation D of the
Securities Act for the offer and sale of the shares. We believed that Section
4(2) was available because the offer and sale did not involve a public offering
and there was no general solicitation or general advertising involved in the
sale. Jeffrey Hall had a pre-existing relationship with Lam Ko Chau, our sole
Officer and Director. We placed legends on the stock certificates stating that
the securities were not registered under the Securities Act and set forth the
restrictions on their transferability and sale.

                                      -16-

On July 29, 2003, we issued 150,000 shares of our common stock to Anthony
Kerrigone in exchange for general consulting services rendered to us between
January 1, 2003 and July 25, 2003. We valued these shares at $0.055 per share or
an aggregate of $8,250. We relied upon the exemption provided in Section 4(2)
and Rule 506 of Regulation D of the Securities Act for the offer and sale of the
shares. We believed that Section 4(2) was available because the offer and sale
did not involve a public offering and there was no general solicitation or
general advertising involved in the sale. Anthony Kerrigone had a pre-existing
relationship with Lam Ko Chau, our sole Officer and Director. We placed legends
on the stock certificates stating that the securities were not registered under
the Securities Act and set forth the restrictions on their transferability and
sale.

On August 1, 2003, we issued 150,000 shares of our common stock to Kojon
Biometrics, Inc., in exchange for consulting services for research and
development, rendered by Lam Ko Chau, on behalf of Kojon Biometrics, Inc. and to
reimburse expenses paid by Kojon in the amount of $64,152. We relied upon the
exemption provided in Section 4(2) and Rule 506 of Regulation D of the
Securities Act for the offer and sale of the shares. We believed that Section
4(2) and Rule 506 were available because the offer and sale did not involve a
public offering and there was no general solicitation or general advertising
involved in the sale. Kojon Biometrics is controlled by Lam Ko Chau, our sole
Officer and Director. We placed legends on the stock certificates stating that
the securities were not registered under the Securities Act and set forth the
restrictions on their transferability and sale. On August 14, 2003, Kojon
distributed 60,000 of these shares to its shareholder, B Investments, Inc., an
Oregon corporation which is owned and controlled by Jean Babalis. On August 14,
2003, Kojon distributed 16,000 of these shares to its shareholder, Protec
International SA, a Belize corporation which is controlled by Richard C. Pike.
On August 14, 2003, Kojon distributed 20,000 of these shares to its shareholder,
Spencer Chen. On August 14, 2003, Kojon distributed 40,000 of these shares to
its shareholder, G. Bryan Thomas.

On October 16, 2003, we issued 500,000 shares of our common stock to Apollo
Holdings Limited, in exchange for consulting services relating to financial
consulting in the European Markets particularly Germany. These services were
rendered by Chris Bonvini on behalf of Apollo Holdings Limited. We valued these
shares at $0.50 per share or an aggregate of $250,000. We relied upon the
exemption provided in Section 4(2) and Rule 506 of Regulation D of the
Securities Act for the offer and sale of the shares. We believed that Section
4(2) and Rule 506 were available because the offer and sale did not involve a
public offering and there was no general solicitation or general advertising
involved in the sale. We placed legends on the stock certificates stating that
the securities were not registered under the Securities Act and set forth the
restrictions on their transferability and sale.

                                      -17-

On August 26, 2003, we sold 50,000 shares of our common stock to our existing
shareholder, G. Bryan Thomas, at a price of $0.50 per share or an aggregate of
$25,000. We relied upon Section 4(2) and Rule 506 of Regulation D of the
Securities Act for the sale. We believed that Section 4(2) and Rule 506 were
available because the sale did not involve a public offering and there was no
general solicitation or general advertising involved in the sale. G. Bryan
Thomas had a pre-existing relationship with Lam Ko Chau, our sole Officer and
Director. G. Bryan Thomas represented to us that he was purchasing the shares
for investment purposes without a view towards resale. We placed legends on the
stock certificates stating that the securities were not registered under the
Securities Act and set forth the restrictions on their transferability and sale.

On August 26, 2003, we sold 20,000 shares of our common stock to Spencer C.
Chen, at a price of $0.50 per share or an aggregate of $10,000. We relied upon
Section 4(2) and Rule 506 of Regulation D of the Securities Act for the sale. We
believed that Section 4(2) and Rule 506 were available because the sale did not
involve a public offering and there was no general solicitation or general
advertising involved in the sale. Spencer C. Chen had a pre-existing
relationship with Lam Ko Chau, our sole Officer and Director. Spencer C. Chen
represented to us that he was purchasing the shares for investment purposes
without a view towards resale. We placed legends on the stock certificates
stating that the securities were not registered under the Securities Act and set
forth the restrictions on their transferability and sale.

On September 18, 2003, we sold 40,000 shares of our common stock to Dr. Javaid
I. Sheikh, at a price of $0.50 per share or an aggregate of $20,000. We relied
upon Section 4(2) and Rule 506 of Regulation D of the Securities Act for the
sale. We believed that Section 4(2) and Rule 506 were available because the sale
did not involve a public offering and there was no general solicitation or
general advertising involved in the sale. Dr. Javaid I. Sheikh had a
pre-existing relationship with Lam Ko Chau, our sole Officer and Director.
Javaid I. Sheikh represented to us that he was purchasing the shares for
investment purposes without a view towards resale. We placed legends on the
stock certificates stating that the securities were not registered under the
Securities Act and set forth the restrictions on their transferability and sale.

On November 7, 2003, we sold 40,000 shares of our common stock to Steven
Grzywacz, at a price of $0.50 per share or an aggregate of $20,000. We relied
upon Section 4(2) and Rule 506 of Regulation D of the Securities Act for the
sale. We believed that Section 4(2) and Rule 506 were available because the sale
did not involve a public offering and there was no general solicitation or
general advertising involved in the sale. Steven Grzywacz had a pre-existing
relationship with Lam Ko Chau, our sole Officer and Director. Steven Grzywacz
represented to us that he was purchasing the shares for investment purposes
without a view towards resale. We placed legends on the stock certificates
stating that the securities were not registered under the Securities Act and set
forth the restrictions on their transferability and sale.

                                      -18-

On November 7, 2003, we sold 36,000 shares of our common stock to Mark
Ouellette, at a price of $0.50 per share or an aggregate of $18,000. We relied
upon Section 4(2) and Rule 506 of Regulation D of the Securities Act for the
sale. We believed that Section 4(2) and Rule 506 were available because the sale
did not involve a public offering and there was no general solicitation or
general advertising involved in the sale. Mark Ouellette had a pre-existing
relationship with Lam Ko Chau, our sole Officer and Director. Mark Ouellette
represented to us that he was purchasing the shares for investment purposes
without a view towards resale. We placed legends on the stock certificates
stating that the securities were not registered under the Securities Act and set
forth the restrictions on their transferability and sale.

Defaults Upon Senior Securities
None.

Submission of Matters to a Vote of Security Holders
None.

Other Information
None.

Exhibits and Reports on Form 8-K
 (a)     Exhibits and Index of Exhibits

Exhibit
Number                         Description
 3.1     Articles of Incorporation of 3045 Corporation dated October 26, 1999(1)
 3.2     Bylaws of 3045 Corporation dated October 25, 1999(1)
10.1     Assignment dated February 27, 2003(2)
10.2     Agreement with Chris LeClerc(3)
10.3     Agreement with Jeffrey L. Hall(3)
31.1     Certification of Chief Executive Officer and Chief Financial Officer
         pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1     Certification of Chief Executive Officer and Chief Financial Officer
         pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906
         of the Sarbanes-Oxley Act of 2002
----------------
  (1) Denotes previously filed exhibits: filed on January 7, 2000 with 3045
        Corporation's Form SB-2 registration statement, file # 333-94265.
  (2) Denotes previously filed exhibits: filed on May 30, 2003 with Liska
        Biometry, Inc.'s Form 10-KSB for the period ended December 31, 2001.
  (3) Denotes previously filed exhibits: filed on August 15, 2003 with Liska
        Biometry, Inc.'s Form 10-QSB for the period ended June 30, 2003.

                                      -19-

We hereby incorporate the following additional documents by reference: (a) our
Form 10-KSB for the year ended December 31, 2002 which was filed on July 28,
2003, for the year ended December 31, 2001 which was filed on May 30, 2003; and
for the year ended November 30, 2000 which was filed on January 3, 2001; (b) our
Registration Statement on Form SB-2 and all amendments thereto which was filed
on January 7, 2000 and amended on February 8, 2000, March 1, 2000, March 14,
2000, April 3, 2000, and April 4, 2000; (c) our Forms 10-QSB for the periods
ended June 30, 2003 which was filed on August 15, 2003; March 31, 2003 which was
filed on August 15, 2003; September 30, 2002 which was filed on July 28, 2003;
June 30, 2002 which was filed on May 30, 2003; March 31, 2002 which was filed on
May 30, 2002; June 30, 2001 which was filed on April 4, 2002; September 30, 2001
which was filed on April 4, 2002; March 31, 2001 which was filed on May 21,
2001; August 31, 2000 which was filed on September 15, 2000; May 31, 2000 which
was filed on June 20, 2000; and February 29, 2000 which was filed on April 14,
2000.

(b)  Reports on Form 8-K
None

                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.

Dated: November 12, 2003

Liska Biometry, Inc.

By: /s/ Lam Ko Chau
        Lam Ko Chau, President, Chief Financial Officer
        and Principal Accounting Officer

                                      -20-
```